Navigation Links
United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
Date:2/15/2011

ecember 31,Three Months EndedDecember 31,201020092008200720102009Net (loss) income, as reported

$

105,916$

19,462$

(49,327)$

12,353$

9,544$

(3,330)Add (subtract) non-cash charges:Interest expense

19,71412,87511,43914,2815,4593,659Income tax expense (benefit)

41,923(695)(34,394)(7,876)(5,039)(1,403)License fees

——150,000(1)

11,013(2)——Depreciation and amortization

17,92011,3944,5363,4273,7394,721Impairment charges

6,1775,4571,6053,5826,1775,058Share-based compensation

113,636100,81036,39348,76652,55827,502Earnings before non-cash charges

$

305,286$

149,303$

120,252$

85,546$

72,438$

36,207Earnings before non-cash charges per share:Basic

$

5.44$

2.80$

2.63$

1.98$

1.27$

0.67Diluted

$

5.13$

2.66$

2.41$

1.87$

1.17$

0.62Weighted average number of common shares outstanding:Basic56,14253,31445,80242,44857,18753,926Diluted59,51656,13349,90044,90261,71557,944(1) During the three months ended December 31, 2008, we made an upfront payment of $150.0 million to Eli Lilly and Company (Lilly) as required by our license and manufacturing and supply agreements. We also issued approximately 6.3 million shares of our common stock to Lilly in exchange for $150.0 million under a stock purchase agreement entered into together with the license and manufacturing and supply agreements. Because there was no net impact on our cash flows associated with these transactions, we have presented the related up-front payment as an adjustment to net loss.(2) During the year ended December 31, 2007, we issued 400,000 shares of our common stock to Toray Industries, Inc. The fair value of the shares issued was expensed as research and development.Conference CallWe will host a half-hour teleconference on Tuesday, Febr
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
2. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
3. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
4. United Therapeutics to Announce Third Quarter 2008 Financial Results Before Market Open on Thursday, October 30, 2008
5. International Drug & Explosive Detection Firm Identa Corp Releasing: Jant Pharmacal Corporation Reports Successful Market Penetration of the Accutest(R) IDenta Co-brand in the United States and Oversees
6. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
7. Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
8. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
9. United Therapeutics Reports Third Quarter 2008 Financial Results
10. Lilly Contributes $11.1 Million to United Way Annual Campaign
11. First United Kingdom Patients Treated With Percutaneous MitraClip(R) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... November 20, 2014 BlueInGreen, LLC ... Solutions, LLC (Pinnacle), and PCI, Inc., leading suppliers ... they have been selected to provide a new ... Arkansas Paul R. Noland Wastewater Treatment. The ... HyDOZ® gas dissolution technology, Pinnacle Ozone’s ...
(Date:11/21/2014)... , Nov. 20, 2014 Polaris Group ... dosed in its Phase 1 trial of ADI-PEG ... the treatment of malignant pleural mesothelioma (MPM) and ... conducting clinical trials on ADI-PEG 20, both as ... the treatment of several other indications, including breast ...
(Date:11/18/2014)... BRUNO, Calif. , Nov. 18, 2014 ... a platinum sponsor of the 10th Annual World Stem Cell ... regenerative medicine stakeholders. The 2014 World Stem Cell Summit will ... San Antonio, Texas . The ... discovery and development of lifesaving cures and therapies, convening the ...
(Date:11/18/2014)... 2014 Athena Signature Series: Turning Cancer ‘Off’ ... Emerson, a professor in the Regulatory Biology Laboratory at the ... discovery points to an “off switch” for drug resistance in ... her local research is making a global impact in the ... then join host Cheryl K. Goodman, CEO of Social Global ...
Breaking Biology Technology:City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3
... (Nasdaq: GENR ) today announced that Jack Armstrong, President,and ... the BIO,Business Forum. The presentation will provide an update on ... Convention Center in San,Diego on Tuesday, June 17, 2008 at ... join a panel of experts to discuss new advancements,in the ...
... Program Supports Development of Strong Scientific Capacity in ... Charitable,Trusts and the University of California at San ... have been named 2008 Pew,Latin American Fellows in ... to UCSF, the highly competitive fellowship program offers ...
... community, LISLE, Ill., June 12 ... retirement community located in Chicago,s,western suburbs, announces ... site,( http://www.VillaStBen.org ). The new site depicts ... in-depth information and support for,residents, prospective seniors, ...
Cached Biology Technology:Genaera Corporation to Present at BIO Business Forum 2Genaera Corporation to Present at BIO Business Forum 3Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences 2Villa St. Benedict Announces New Web Site 2
(Date:11/21/2014)... -- C-Labs LLC, a leading provider of remote and ... announced the appointment of John Traynor to ... advisor to the firm, Mr. Traynor will now oversee ... out of the C-Labs office in Redmond, ... , Chief Executive Officer. Photo - ...
(Date:11/18/2014)... NEW YORK , Nov. 18, 2014 /PRNewswire/ ... iris-based identity authentication solutions, and MorphoTrust USA ... solutions and services, today announced a strategic partnership ... across enterprise, motor vehicle administration (MVA), airport screening ... leader in identity-related solutions, MorphoTrust serves consumers through ...
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... researchers think their discovery of the enzyme involved in ... lead not only to better pest control, but also ... aircraft and armor. , After a beetle first molts, ... out and forms a hard, stiff exoskeleton. Since the ...
... antibody engineered by scientists at The University of Texas ... the use of antibiotics and other more expensive antibodies. ... both anthrax bacteria and its deadly toxins in animal ... first successful treatment for late-stage anthrax infection, even for ...
... at Stanford University have created a larger-than-normal DNA molecule ... The findings, reported in the Oct. 25 online edition ... (PNAS), may reveal new insights into how genetic mutations-tiny ... made in the laboratory of Eric Kool, a professor ...
Cached Biology News:K-State professors discover enzyme responsible for creation of a beetle's hard shell 2New antibody shows promise as cure for anthrax 2New antibody shows promise as cure for anthrax 3DNA size a crucial factor in genetic mutations, study finds 2DNA size a crucial factor in genetic mutations, study finds 3
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
... The 2/3D Waver Shaker combines shaking and ... with a 330 x 330 mm stainless steel ... top incubator and cold room operation. The platform ... degree for a vigorous with action and rotation ...
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
... The Experion HighSens analysis kit for 25 ... to perform high-sensitivity RNA analysis (at picogram ... This kit includes 25 RNA HighSens microfluidic ... 2 x 20 microliters RNA HighSens stain, ...
Biology Products: